Related Experiment Video
Updated: May 25, 2026

06:11
Uncontrolled Hemorrhagic Shock Modeled via Liver Laceration in Mice with Real Time Hemodynamic Monitoring
Published on: May 21, 2017
8.5K
Aryl Organophosphate Esters and Hemostatic Disruption: Identifying Risk through Machine Learning and Experimental
Pu Chen1, Ziyuan Li1, Gan Miao1
1Department of Occupational and Environmental Health, School of Public Health, Qingdao University, Qingdao 266071, China.
Environmental Science & Technology
|May 20, 2025
Summary
Organophosphate esters (OPEs) disrupt blood hemostasis, particularly aryl-OPEs. Proliferator-activated receptor gamma (PPARγ) mediates this disruption, posing a moderate risk to public health.
Area of Science:
- Environmental Health
- Toxicology
- Hematology
Background:
- Organophosphate esters (OPEs) are widespread environmental contaminants with potential human health risks.
- OPEs in blood suggest hematological interactions, potentially compromising hemostatic balance.
- The impact of OPEs on hemostasis is not well understood.
Purpose of the Study:
- To investigate the effects and mechanisms of OPEs on hemostasis.
- To identify specific OPEs that disrupt hemostatic balance.
- To elucidate the molecular pathways involved in OPE-induced hemostatic dysfunction.
Main Methods:
- Computational analysis of 85 prevalent OPEs for structural properties and protein affinity.
- High-throughput in vitro hemostatic balance assays.
- Network toxicology, AI (α-Fold), and agonist cotreatment assays to identify mediator proteins.
Main Results:
- Aryl-OPEs, characterized by a benzene ring, were identified as potent hemostatic disruptors.
- Proliferator-activated receptor γ (PPARγ) was identified as a key mediator of aryl-OPE induced hemostatic disruption.
- Specific OPEs, including bisphenol a bis (diphenyl phosphate) (BDP) and cresyl diphenyl phosphate (CDP), were found to pose a moderate risk.
Conclusions:
- Aryl-OPEs present a moderate risk to the hemostatic balance of the general population.
- PPARγ is a critical mediator in OPE-induced hemostatic disruption.
- The study provides a methodology for assessing the hematological toxicity of emerging pollutants.
Related Concept Videos
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

